Business duo Stuart Weisbrod and Jacob Gottlieb have actively competed and worked together in the healthcare business. Weisbrod is among the co-founders of Merlin which concentrates on pharmaceuticals, biotechnology, healthcare services and medical devices. Weisbrod has successfully set an outstanding track record holding critical positions in Harpel Partners, Oracle Partners, and Merrill Lynch.
With such an outstanding professional bio, he teamed up with Jacob Gottlieb to build the biotechnology revolution. Jacob used to work as a portfolio manager in Weisbrod helping Merlin accumulate over one hundred percent returns between 1999 and 2000. Substantial returns attracted numerous clients including endowments, pension funds as well as family offices.
Later, Weisbrod founded an investment firm known as Iguana Healthcare Partners which would work like Merlin only that it would actively concentrate on the public companies in the healthcare department. The changing environment in which world assist reptiles to survive many years inspires the name Iguana Company.
Gottlieb started the Visium Asset Management which he managed until the company grew to the point of being a multi-billion company. However, the Visium Asset Management company faced challenges to the point of coming to an end. According to a research done by Jason Thorell, three key executives participated in insider mismarking and trading which he tabled the evidence for the SEC and the FBI.
Despite the company public destruction, the Visium Company stills hold Gottlieb as the CEO, and they have agreed to pay the fine. Nevertheless, Gottlieb has joined a new company called Altium Capital. Their technology has positively transformed medical treatments thus being a good move by Investing in the Oramed Pharmaceutical Inc. The move will positively impact millions of people undergoing therapies and diabetes. Oramed seeks to get approved by the FDA as well as reduce the treatment costs and infection rates. Notably, Gottlieb is greatly revolutionizing the pharmaceutical industry due to his investment in Oramed.